Johnson & Johnson beats by $0.04, beats on revenue


Johnson & Johnson (JNJ): Q4 EPS of $1.24 beats by $0.04.

Revenue of $18.4B (+4.8% Y/Y) beats by $450M.

From other sites
Comments (10)
  • Doug Meeks
    , contributor
    Comments (1908) | Send Message
     
    Nicely done, JNJ. Thanks! A core holding for me, staying Long JNJ.
    21 Jan 2014, 09:17 AM Reply Like
  • tomlos
    , contributor
    Comments (1298) | Send Message
     
    Staying long JNJ as well and will add much more down the road. What a tremendous company that with Gorsky is firing on all cylinders.
    21 Jan 2014, 09:24 AM Reply Like
  • positivethoughts
    , contributor
    Comments (2065) | Send Message
     
    Why would anyone invest in long term government bonds as opposed to companies like JNJ or XOM?
    21 Jan 2014, 09:39 AM Reply Like
  • Doug Meeks
    , contributor
    Comments (1908) | Send Message
     
    People are just afraid of the market. Also, JNJ is a dividend growth company and few investors have the dividend growth idea, when your JNJ is buried deep inside a mutual fund all you know is that you lost 50% in 2008/9. So most don't know that JNJ has double the dividend since 2005, they raised it 11% in 2008 and 8% in 2009.
    21 Jan 2014, 10:10 AM Reply Like
  • tomlos
    , contributor
    Comments (1298) | Send Message
     
    You are spot on with this.. people are afraid of the market, and when I took over our retirement about two years ago and now do strictly DGI, it opened my eyes entirely. Why anyone would ever buy their young children bonds is beyond me.. Buy them a piece of a free cash flow machine that continues to grow. Just common sense..
    21 Jan 2014, 10:25 AM Reply Like
  • Slick E
    , contributor
    Comments (150) | Send Message
     
    So why is JNJ down over 2% today? Was the market expecting them to beat by more?
    21 Jan 2014, 10:59 AM Reply Like
  • positivethoughts
    , contributor
    Comments (2065) | Send Message
     
    The market is irrational. Amazon can lose money and their stock will rise. JNJ can beat and earn income and can fall. JNJ is long term. If you buy it today, in 10 - 15 years, you will probably earn nice returns from it. Companies like Amazon eventually will have to earn money, and if they dont, some people will get real poor, real fast.
    21 Jan 2014, 01:08 PM Reply Like
  • Doug Meeks
    , contributor
    Comments (1908) | Send Message
     
    JNJ provided guidance to the low side of 2014 estimates. It is common for investors to sell the good news as well. Finally earnings that beat estimates have real positive price pressure only when estimates are raised or a "beat and raise". This was great news for long term dividend income investors, but for trading it was just another day in the up and down price market. I own the earnings by being a long term shareholder ( and director of many shareholder accounts) so I will be looking forward to yet another dividend increase which will be more than 50 years in a row for JNJ.
    21 Jan 2014, 11:13 AM Reply Like
  • jstratt
    , contributor
    Comments (3981) | Send Message
     
    JNJ is one of the few buys in the market. An investment at $93 could expect a 10% gain in 2014 without stretching valuation. I need to review the conference call regarding the tax on devices. On the surface I find it hard to believe a tax would affect whether one chooses a hip or knee replacement.
    21 Jan 2014, 12:46 PM Reply Like
  • Doug Meeks
    , contributor
    Comments (1908) | Send Message
     
    I think the tax is a matter of total price. In many cases the payer of a procedure like those is not the person getting the knee, it's often settled by the insurance companies (or a state plan like medicaid) and they might ask JNJ to absorb some of the added cost, and that pass around is not just for joint replacements it could result in the lost of a fraction of a point from drugs as well. Also there is the worry of delayed payments and such. They will get it worked out.
    21 Jan 2014, 03:12 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs